Pulse Biosciences Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Pulse Biosciences.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 17.6% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Pulse Biosciences Stock: Signs Of Life Following Q1 Update
May 16We're Keeping An Eye On Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate
May 10We Think Pulse Biosciences (NASDAQ:PLSE) Can Afford To Drive Business Growth
Dec 25We Think Pulse Biosciences (NASDAQ:PLSE) Can Afford To Drive Business Growth
Sep 04Pulse Biosciences (NASDAQ:PLSE) Has Debt But No Earnings; Should You Worry?
Mar 08Pulse Biosciences appoints Kevin Danahy as CEO; Darrin Uecker to serve as CTO
Sep 20Companies Like Pulse Biosciences (NASDAQ:PLSE) Could Be Quite Risky
Apr 04Is Pulse Biosciences (NASDAQ:PLSE) Using Debt In A Risky Way?
Oct 29Pulse Biosciences gets Health Canada approval for CellFX System
Jun 09Is Pulse Biosciences (NASDAQ:PLSE) In A Good Position To Invest In Growth?
Mar 31Who Has Been Buying Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares?
Feb 24Pulse Biosciences establishes at-the-market equity program
Feb 04What Percentage Of Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Do Insiders Own?
Jan 20Pulse Biosciences' CellFX System U.S. application moves forward for general dermatology indication
Jan 12We're Keeping An Eye On Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate
Dec 16In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pulse Biosciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | N/A | -44 | -36 | -35 | N/A |
3/31/2024 | N/A | -43 | -36 | -36 | N/A |
12/31/2023 | N/A | -42 | -33 | -33 | N/A |
9/30/2023 | 0 | -39 | -34 | -34 | N/A |
6/30/2023 | 0 | -47 | -35 | -34 | N/A |
3/31/2023 | 0 | -51 | -38 | -38 | N/A |
12/31/2022 | 1 | -59 | -47 | -47 | N/A |
9/30/2022 | 2 | -65 | -52 | -52 | N/A |
6/30/2022 | 2 | -61 | -55 | -54 | N/A |
3/31/2022 | 2 | -62 | -59 | -58 | N/A |
12/31/2021 | 1 | -64 | -55 | -54 | N/A |
9/30/2021 | 1 | -62 | -51 | -51 | N/A |
6/30/2021 | N/A | -61 | -46 | -46 | N/A |
3/31/2021 | N/A | -57 | -38 | -37 | N/A |
12/31/2020 | N/A | -50 | -36 | -35 | N/A |
9/30/2020 | N/A | -50 | -35 | -35 | N/A |
6/30/2020 | N/A | -49 | -35 | -35 | N/A |
3/31/2020 | N/A | -49 | -37 | -36 | N/A |
12/31/2019 | N/A | -47 | -35 | -34 | N/A |
9/30/2019 | N/A | -42 | -32 | -31 | N/A |
6/30/2019 | N/A | -41 | -30 | -30 | N/A |
3/31/2019 | N/A | -39 | -26 | -26 | N/A |
12/31/2018 | N/A | -38 | -24 | -24 | N/A |
9/30/2018 | N/A | -37 | -22 | -22 | N/A |
6/30/2018 | N/A | -34 | -18 | -18 | N/A |
3/31/2018 | N/A | -31 | N/A | -14 | N/A |
12/31/2017 | N/A | -26 | N/A | -11 | N/A |
9/30/2017 | N/A | -20 | N/A | -9 | N/A |
6/30/2017 | N/A | -15 | N/A | -8 | N/A |
3/31/2017 | N/A | -11 | N/A | -9 | N/A |
12/31/2016 | N/A | -10 | N/A | -8 | N/A |
9/30/2016 | N/A | -8 | N/A | -7 | N/A |
6/30/2016 | N/A | -6 | N/A | -6 | N/A |
3/31/2016 | N/A | -4 | N/A | -4 | N/A |
12/31/2015 | N/A | -3 | N/A | -3 | N/A |
9/30/2015 | N/A | -2 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PLSE's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if PLSE's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if PLSE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PLSE's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if PLSE's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PLSE's Return on Equity is forecast to be high in 3 years time